CHIP, OXYGEN

The contract involves the procurement of one unit of CHIP, OXYGEN, a medical diagnostic item containing ten measurement capillaries filled with a substance-specific reagent system designed to measure oxygen levels in the range of 1.0 to 25.0 volume percent, with a total of ten tests per unit. The item is identified by NSN 6550-01-530-8046 and is subject to strict technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, with compliance enforced through designated R and I numbers. Delivery is mandated within 20 days after order date, with the destination set at Thumrait, Oman, under FOB Destination terms. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed between the date of manufacture and delivery to the government. All labeling must include the date of manufacture, expiration or retest date, contract number, and lot number, in accordance with the latest revision of Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129, and shelf-life markings must conform to MMS1C. Packaging must meet commercial standards, using sealed unit containers and suitable exterior shipping containers to ensure safe transit and compliance with export requirements when applicable. Hazardous materials handling must adhere to IP025 and OSHA’s Hazard Communication Standard, with appropriate labeling required under DFARS clause 252.223-7001. The item is also subject to safeguarding requirements for covered defense information under NIST SP 800-171 and DFARS clauses, requiring contractor systems to meet cyber compliance benchmarks. Invoicing must be conducted electronically via Wide Area WorkFlow, and payment administration is governed by DoDAACs and electronic payment instructions. Offerors must provide a Unique Entity ID and comply with representations regarding small business status, socioeconomic designations, and disclosure of covered defense telecommunications equipment. The solicitation was issued under a simplified acquisition process through DIBBS with a response deadline of May 26, 2026, and is administered by the Department of Defense’s Medical Supply Chain.